2021-2022 fluarix and flulaval vaccine delivery order. For DOS account.

Ended Awarded Last action

Contract number
19AQMM21F3172
Awardee
Awarding agency
Obligated
$708,589

Award facts

Contract value 100% obligated
$708,588.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Bureau of Administration Department of State
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sterling, VA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $48,157
Original award $660,432

About this award

The 2021-2022 FLUARIX AND FLULAVAL VACCINE DELIVERY ORDER, valued at $708,588.50, was awarded by the Department of State Bureau of Administration to Glaxosmithkline, LLC for delivery of influenza vaccines. Glaxosmithkline will provide its FLUARIX and FLULAVAL vaccines to the Department of State under the terms of this firm fixed price delivery order, which was issued against Glaxosmithkline's GSA Schedule contract for pharmaceuticals and drugs. Performance will occur in Sterling, Virginia through November 2021. No subcontractors or set-aside designations were identified. This order supports the Department of State's ongoing public health efforts by procuring influenza vaccinations for distribution to personnel.

Quick answers

Who was awarded contract 19AQMM21F3172?

19AQMM21F3172 was awarded to Glaxosmithkline, LLC by Office of Acquisition Management (Department of State) on August 18, 2021.

How much is contract 19AQMM21F3172 worth?

The government has obligated $708,589 on 19AQMM21F3172.

Which agency awarded contract 19AQMM21F3172?

Office of Acquisition Management (Department of State) awarded 19AQMM21F3172, with funding from Bureau of Administration (Department of State).

Is contract 19AQMM21F3172 an order under another contract?

Yes. 19AQMM21F3172 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 19AQMM21F3172 competed?

The extent of competition for 19AQMM21F3172 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award